Article
Precision neoantigen discovery using large-scale immunopeptidomes and composite modeling of MHC peptide presentation
2021-05-01
Abstract excerpt
Major histocompatibility complex (MHC)-bound peptides that originate from tumor-specific genetic alterations, known as neoantigens, are an important class of anti-cancer therapeutic targets. Accurately predicting peptide presentation by MHC complexes is a key aspect of discovering therapeutically relevant neoantigens. Technological improvements in mass-spectrometry-based immunopeptidomics and advanced modeling tec...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 70624a50-9feb-5f9d-b6e4-c879d336de6c
- DOI
- 10.1101/2021.04.30.442203
